Chitosan nanoparticles: Polyphosphates cross-linking and protein delivery properties

被引:49
作者
Abdelgawad, Abdelrahman M. [1 ,2 ]
Hudson, Samuel M. [2 ]
机构
[1] Natl Res Ctr, Text Res Div, Cairo, Egypt
[2] North Carolina State Univ, Coll Text, Fiber & Polymer Sci Program, Campus Box 8301, Raleigh, NC USA
关键词
Chitosan; Hexametaphosphate; Drug delivery;
D O I
10.1016/j.ijbiomac.2019.06.062
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nanoparticles from chitosan, in general, can be prepared through ionotropic gelation, physical crosslinking, with anionic polyphosphates. Tripolyphosphate (TPP) is widely used for such purpose especially in drug delivery applications. TPP is a small ion with a triple negative charge throughout the physiologically acceptable pH range. However, the stability of size and surface charge of the particles still challenging. In the current work, the utilization of Hexametaphosphate (HMP) instead of Tripolyphosphate (TPP) as a cross-linking agent is being investigated. HMP is hexavalent molecule in the neutral and slightly basic medium which offers more binding sites readily available for interaction with chitosan. It is thought that increasing the availability of the binding sites in the HMP molecule would result in stronger ionic complexation with chitosan cationic charges. Consequently, such stronger binding improves particles' stability and lead to average size reduction. A comparative study between chitosan/TPP and chitosan/HMP nanoparticles under different complexation conditions was conducted to investigate the effect of HMP on nanoparticles formation. Bovine Serum Albumin (BSA) was applied as a protein model drug to explore the drug loading efficiency, 96.3%, is higher than its TPP, 91.87%, counterparts. However, TPP cross-linked particles showed superior stability upon storage. (C) 2019 Elsevier B.V. All rights reserved.
引用
收藏
页码:133 / 142
页数:10
相关论文
共 22 条
[1]  
[Anonymous], 1985, J NONCRYS SOLIDS
[2]  
Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
[3]  
2-4
[4]   Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers [J].
Chen, Fu ;
Zhang, Zhi-Rong ;
Huang, Yuan .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 336 (01) :166-173
[5]  
Desai S. M. K., 2008, EUR J PHARM BIOPHARM, P187
[6]   Chitosan nanoparticles preparation and applications [J].
Divya, K. ;
Jisha, M. S. .
ENVIRONMENTAL CHEMISTRY LETTERS, 2018, 16 (01) :101-112
[7]   Chitosan: Aspects of fiber spinnability [J].
El-Tahlawy, K ;
Hudson, SM .
JOURNAL OF APPLIED POLYMER SCIENCE, 2006, 100 (02) :1162-1168
[8]   Protein drug stability: A formulation challenge [J].
Frokjaer, S ;
Otzen, DE .
NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (04) :298-306
[9]   Chitosan nanoparticle as protein delivery carrier - Systematic examination of fabrication conditions for efficient loading and release [J].
Gan, Quan ;
Wang, Tao .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2007, 59 (01) :24-34
[10]  
Gomes LP., 2018, INT J BIOTECHNOL BIO, V12, P111, DOI DOI 10.5281/ZENODO.1340442